Home / Health / GLP-1 Drugs: Beyond Weight Loss, Boosting Heart Health

GLP-1 Drugs: Beyond Weight Loss, Boosting Heart Health

Summary

  • GLP-1 medications improve heart function in obesity-related heart failure.
  • Older adults on GLP-1 drugs experience fewer falls and less dependency.
  • These drugs may reduce healthcare costs and hospital admissions.
GLP-1 Drugs: Beyond Weight Loss, Boosting Heart Health

Recent studies indicate that GLP-1 medications, known for weight loss, may offer broader health advantages. Research presented at Obesity Week 2026 showed that individuals with obesity and heart failure using these drugs experienced improved heart structure and function over a year. These improvements were significant even after accounting for weight loss, suggesting a direct cardiac benefit.

Further findings from the American Heart Association's Scientific Sessions revealed that semaglutide use in adults with a specific type of heart failure led to reduced internal heart pressure and remission in over half of the participants. Separate research also highlighted that older adults (65+) on GLP-1 drugs had a lower risk of falls and wheelchair dependency compared to those on metformin.

Additionally, an analysis of Zepbound users suggested a stabilization of healthcare costs and fewer hospitalizations compared to non-users, indicating potential long-term financial benefits. Studies also linked GLP-1 medication use to improved employment rates. While these findings are promising, further research is needed to confirm long-term effects and overall impact on patient lives.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Read more news on

Property Code: 5571